SCHEMBL24431822

SCHEMBL24431822

COc1ccc(-c2nc(OC)nc(-c3cc4c5ccccc5ccc4c4ccccc34)n2)c(O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.49
▸ CYP11B1 P15538 3/20 0.41
▸ CYP11B2 P19099 3/20 0.41
▸ CYP17A1 P05093 2/20 0.41
▸ MEN1 O00255 8/20 0.40
▸ KMT2A Q03164 8/20 0.40
▸ MAPT P10636 6/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ ATM Q13315 1/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2B6 P20813 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24431965 0.91 KMT2A (0.39) NPC1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL24431824 0.91 NPC1 (0.52) NPC1CYP11B1CYP11B2MEN1KMT2A
SCHEMBL24432575 0.90 NPC1 (0.44) NPC1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL24431839 0.89 AKR1B1 (0.37) NPC1MEN1KMT2AMAPTLMNA
SCHEMBL24431565 0.89 KMT2A (0.45) NPC1MEN1KMT2AMAPTL3MBTL1
SCHEMBL21873279 0.87 MAPK1 (0.49) NPC1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL24431704 0.85 NQO2 (0.36) NPC1MEN1KMT2AMAPTCYP1A2
SCHEMBL24431733 0.84 NPC1 (0.35) NPC1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL24431798 0.84 KMT2A (0.36) MEN1KMT2AMAPTRXFP1CYP1A2
SCHEMBL13886328 0.83 NPC1 (0.68) NPC1MEN1KMT2AMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220158099-A1 DISPLAY APPARATUS AND LIGHT ABSORBER INCLUDED IN DISPLAY APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220158099-A1 DISPLAY APPARATUS AND LIGHT ABSORBER INCLUDED IN DISPLAY APPARATUS CRY1, EPHB4, HTR3D NPC1 3676/4885CYP11B1 4588/4885CYP11B2 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback